Table of Contents Table of Contents
Previous Page  557 / 1851 Next Page
Information
Show Menu
Previous Page 557 / 1851 Next Page
Page Background

Ipilimumab vs. pembrolizumab first-line MMM

Roberts et al NEJM 2015